News
- Author:
- Marlene Busko
Publish date: January 17, 2024
T3 may be an important test to identify subclinical changes in thyroid function, say researchers.
News
- Author:
- Marlene Busko
Publish date: December 6, 2023
“Women with early-life exposures such as early age at menarche need to be further examined for diabetes and prevention research and strategies for ...
News
- Author:
- Marlene Busko
Publish date: November 22, 2023
Finding that 4% of the women in the intervention arm had reduced ejection fraction is “absolutely startling ... and speaks to how important improvi...
News
- Author:
- Marlene Busko
Publish date: November 15, 2023
“This trial identifies a potential need for a paradigm shift in the way women affected by hypertensive pregnancy are managed postnatally,” said Dr....
News
- Author:
- Marlene Busko
Publish date: November 13, 2023
This study is “not a home run,” for the primary outcome, however, many of the outcomes tended to be in favor of a liberal transfusion strategy.
News
- Author:
- Marlene Busko
Publish date: November 8, 2023
“These medications change [the defended fat mass] to something that is more normal, rather than ‘fixing’ it.”
News
- Author:
- Marlene Busko
Publish date: November 1, 2023
With the two highest doses of retatrutide, 100% of participants lost ≥ 5% of weight. “I’m not sure how many other times I will ever be able to say ...
Audio
- Author:
- Marlene Busko
Publish date: October 23, 2023
Future interventions to prevent weight regain should target overeating in response to internal and external food cues and declines in self-monitori...
News
- Author:
- Marlene Busko
Publish date: October 19, 2023
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
News
- Author:
- Marlene Busko
Publish date: October 12, 2023
“I personally think the findings show that we should treat cardiovascular risk factors more aggressively in people diagnosed with [type 2] diabetes...
News
- Author:
- Marlene Busko
Publish date: October 6, 2023
OPT-BIRISK tested an antiplatelet strategy “in challenging patients at increased risk for bleeding and ischemic events, but I don’t think we can sa...
News
- Author:
- Marlene Busko
Publish date: October 3, 2023
“This is the first and only randomized trial to show the superiority of longer duration over shorter duration of anticoagulation therapy for reduci...
News
- Author:
- Marlene Busko
Publish date: September 19, 2023
“For the first time we have an oral agent” that lowers Lp(a) levels. However, “we will still need to determine if this leads to a reduction in ...
News
- Author:
- Marlene Busko
Publish date: August 28, 2023
On the other hand, patients with MI “will benefit from going straight to a heart attack center and having an attempt at reopening the artery.”
News
- Author:
- Marlene Busko
Publish date: August 28, 2023
Diagnosing a lethal, rare, but not uncommon disease such as endocarditis “is something that clinicians struggle with every day,” he noted, pointing...
